180 related articles for article (PubMed ID: 18569459)
1. Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.
Solbrig MV; Hermanowicz N
J Neurovirol; 2008 May; 14(3):252-60. PubMed ID: 18569459
[TBL] [Abstract][Full Text] [Related]
2. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.
Solbrig MV; Fan Y; Hermanowicz N; Morgese MG; Giuffrida A
Exp Neurol; 2010 Nov; 226(1):231-41. PubMed ID: 20832403
[TBL] [Abstract][Full Text] [Related]
3. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
5. Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.
Enayatfard L; Rostami F; Nasoohi S; Oryan S; Ahmadiani A; Dargahi L
Neuromolecular Med; 2013 Sep; 15(3):523-35. PubMed ID: 23794089
[TBL] [Abstract][Full Text] [Related]
6. Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats.
Bortolato M; Bini V; Frau R; Devoto P; Pardu A; Fan Y; Solbrig MV
Eur Neuropsychopharmacol; 2014 Jun; 24(6):974-85. PubMed ID: 24630433
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
Polissidis A; Chouliara O; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
Behav Brain Res; 2014 Aug; 270():261-9. PubMed ID: 24867330
[TBL] [Abstract][Full Text] [Related]
10. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
[TBL] [Abstract][Full Text] [Related]
11. The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling.
Du JJ; Liu ZQ; Yan Y; Xiong J; Jia XT; Di ZL; Ren JJ
J Mol Neurosci; 2020 Mar; 70(3):422-432. PubMed ID: 31732924
[TBL] [Abstract][Full Text] [Related]
12. Borna disease virus infects human neural progenitor cells and impairs neurogenesis.
Brnic D; Stevanovic V; Cochet M; Agier C; Richardson J; Montero-Menei CN; Milhavet O; Eloit M; Coulpier M
J Virol; 2012 Mar; 86(5):2512-22. PubMed ID: 22190725
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain.
Marchalant Y; Brothers HM; Wenk GL
Mol Psychiatry; 2009 Dec; 14(12):1068-9. PubMed ID: 19920834
[No Abstract] [Full Text] [Related]
14. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.
Marchalant Y; Rosi S; Wenk GL
Neuroscience; 2007 Feb; 144(4):1516-22. PubMed ID: 17178196
[TBL] [Abstract][Full Text] [Related]
15. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
18. Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55,212-2.
Tagliaferro P; Javier Ramos A; Onaivi ES; Evrard SG; Lujilde J; Brusco A
Brain Res; 2006 Apr; 1085(1):163-76. PubMed ID: 16566907
[TBL] [Abstract][Full Text] [Related]
19. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2.
Jelsing J; Galzin AM; Guillot E; Pruniaux MP; Larsen PJ; Vrang N
Brain Res Bull; 2009 Mar; 78(4-5):202-10. PubMed ID: 19038314
[TBL] [Abstract][Full Text] [Related]
20. Effects of neonatal rat Borna disease virus (BDV) infection on the postnatal development of the brain monoaminergic systems.
Pletnikov MV; Rubin SA; Schwartz GJ; Carbone KM; Moran TH
Brain Res Dev Brain Res; 2000 Feb; 119(2):179-85. PubMed ID: 10675767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]